{"id":23103,"date":"2011-09-30T23:04:21","date_gmt":"2011-10-01T03:34:21","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=23103"},"modified":"2011-09-30T23:04:21","modified_gmt":"2011-10-01T03:34:21","slug":"guidelines-for-designing-and-reporting-clinical-trials-in-vitiligo","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/23103","title":{"rendered":"Guidelines for Designing and Reporting Clinical Trials in Vitiligo"},"content":{"rendered":"","protected":true},"excerpt":{"rendered":"","protected":true},"author":16,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48],"tags":[],"class_list":["post-23103","post","type-post","status-publish","format-standard","post-password-required","","category-comunicaciones-importantes"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/23103","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=23103"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/23103\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=23103"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=23103"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=23103"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}